MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 229 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,810,330 | -19.5% | 21,681,033 | 0.0% | 13.15% | +4.1% |
| Q2 2023 | $269,495,240 | -11.3% | 21,681,033 | 0.0% | 12.63% | -15.9% |
| Q1 2023 | $303,751,272 | -2.1% | 21,681,033 | 0.0% | 15.02% | -16.7% |
| Q4 2022 | $310,255,582 | -43.9% | 21,681,033 | 0.0% | 18.04% | -44.8% |
| Q3 2022 | $553,517,000 | -10.1% | 21,681,033 | 0.0% | 32.68% | +48.7% |
| Q2 2022 | $615,958,000 | -19.4% | 21,681,033 | 0.0% | 21.97% | -9.3% |
| Q1 2022 | $764,690,000 | -15.8% | 21,681,033 | 0.0% | 24.22% | -12.5% |
| Q4 2021 | $908,435,000 | -14.6% | 21,681,033 | 0.0% | 27.70% | +2.6% |
| Q3 2021 | $1,064,105,000 | +3.6% | 21,681,033 | -11.9% | 26.99% | -5.7% |
| Q2 2021 | $1,027,079,000 | +4.2% | 24,612,474 | -11.0% | 28.61% | +2.9% |
| Q1 2021 | $985,322,000 | +27.1% | 27,646,515 | 0.0% | 27.81% | +43.6% |
| Q4 2020 | $775,485,000 | – | 27,646,515 | – | 19.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |